Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Opioid analgesics

President Trump declares opioid crisis a national emergency

US President Donald Trump has declared the country’s opioid abuse epidemic a national emergency.

The heightened status will give states and local areas access to federal funds reserved for emergencies, such as those used for responding to disease outbreaks or natural disasters. It should also provide the government with greater flexibility to waive rules and regulations to allow states to take action against the epidemic.

However, it is not yet clear on the specific nature of the emergency declaration and if the response will be short- or long-term. 

President Trump’s statement follows an interim report from the Commission on Combating Drug Addiction and the Opioid Crisis, which concluded that the declaration of a national emergency is the most pressing response to the crisis.

It is estimated that there are 142 opioid-related deaths in the United States every day, which the Commission compared to the 9/11 death toll happening every three weeks. The number of opioid overdoses has quadrupled since 1999.

“The opioid crisis is an emergency, and I am saying, officially, right now, it is an emergency. It’s a national emergency,” President Trump said on Thursday. “We’re going to spend a lot of time, a lot of effort and a lot of money on the opioid crisis.”

The opioid crisis is the first national emergency to be declared during the Trump presidency and the 29th currently active in the United States, which include the oldest national emergency blocking Iranian government property, invoked by President Carter in 1979.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203410

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Donald Trump US president

Similar topics

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.